Delivery Order SPE2DB24D3013-SPE2DB25FFPSZ
- Not listed
- The Defense Logistics Agency awarded a $17,742.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor under the agency's pharmaceutical supply chain and fulfills this order from its corporate office location. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a $25,845.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive support for federal medical procurement...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $15,087.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. This non-set-aside delivery order represents a routine pharmaceutical procurement through the federal medical supply chain....
- The Defense Logistics Agency awarded a delivery order valued at $14,404.90 to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract arrangement and represents a pharmaceutical supply transaction for federal medical procurement. The award was performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $12,440.50 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and represents a non-set-aside, competitively awarded procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $41,875.77 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $15,735.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by July 31, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely used...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPSZDelivery Order
The Defense Logistics Agency awarded a $15,030.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 25, 2025. This award, issued on August 22, 2025, represents a non-set-aside competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this delivery order under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is part of AmerisourceBergen's extensive portfolio supporting military and veteran healthcare systems through the DLA Medical Supply Chain. Eliquis is an anticoagulant medication commonly used in federal healthcare programs, and this procurement exemplifies the company's role as a primary vendor for pharmaceutical commodities across therapeutic domains. The firm fixed-price structure and competitive award demonstrate AmerisourceBergen's established capability to meet federal medical supply requirements through open competition, consistent with its participation in the DLA's comprehensive Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 8/22/25 |